CEO Steps Down from Troubled Ecstasy-Drug Company
Wall Street Journal
The leadership change comes after psychedelic drugmaker Lykos lost its bid for FDA approval.
https://www.wsj.com/articles/ceo-steps-down-from-troubled-ecstasy-drug-company-b7d91fbc